The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages

Infection and Immunity

Volumn 82, Issue 9, 2014, Pages 3523-3530

  Moonah, Shannon N ^a   Abhyankar, Mayuresh M ^a   Haque, Rashidul ^b   Petri, William A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AMEBIASIS; ARTICLE; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; ENDEMIC DISEASE; ENTAMOEBA HISTOLYTICA; HOST; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MACROPHAGE; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TISSUE INJURY; TROPHOZOITE;

ANIMALS; ANTIBODIES; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CYTOPLASM; ENTAMOEBA HISTOLYTICA; GLUCOCORTICOIDS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOMODULATION; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MAMMALS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906070288     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01812-14     Document Type: Article

References (62)

1. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C. 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375:1969-1987. http://dx.doi.org/10.1016/S0140-6736(10)60549-1.
2. KotloffKL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209-222. http://dx.doi.org/10.1016/S0140-6736(13)60844-2.
3. Taniuchi M, Sobuz SU, Begum S, Platts-Mills JA, Liu J, Yang Z, Wang XQ, Petri WA, Jr, Haque R, Houpt ER. 2013. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J. Infect. Dis. 208:1794-1802. http://dx.doi.org/10.1093/infdis/jit507.
4. Moonah SN, Jiang NM, Petri WA, Jr. 2013. Host immune response to intestinal amebiasis. PLoS Pathog. 9:e1003489. http://dx.doi.org/10.1371/journal.ppat.1003489.
5. Peterson KM, Shu J, Duggal P, Haque R, Mondal D, Petri WA, Jr. 2010. Association between TNF-alpha and Entamoeba histolytica diarrhea. Am. J. Trop. Med. Hyg. 82:620-625. http://dx.doi.org/10.4269/ajtmh.2010.09-0493.
6. Zhang Z, Mahajan S, Zhang X, Stanley SL, Jr. 2003. Tumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SCID mouse-human intestinal xenograft model of disease. Infect. Immun. 71:5355-5359. http://dx.doi.org/10.1128/IAI.71.9.5355-5359.2003.
7. Helk E, Bernin H, Ernst T, Ittrich H, Jacobs T, Heeren J, Tacke F, Tannich E, Lotter H. 2013. TNFalpha-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infection. PLoS Pathog. 9:e1003096. http://dx.doi.org/10.1371/journal.ppat.1003096.
8. Calandra T, Roger T. 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3:791-800. http://dx.doi.org/10.1038/nri1200.
9. Roger T, David J, Glauser MP, Calandra T. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414:920-924. http://dx.doi.org/10.1038/414920a.
10. Kudrin A, Scott M, Martin S, Chung CW, Donn R, McMaster A, Ellison S, Ray D, Ray K, Binks M. 2006. Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J. Biol. Chem. 281: 29641-29651. http://dx.doi.org/10.1074/jbc. M601103200.
11. Alam A, Haldar S, Thulasiram HV, Kumar R, Goyal M, Iqbal MS, Pal C, Dey S, Bindu S, Sarkar S, Pal U, Maiti NC, Bandyopadhyay U. 2012. Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor. J. Biol. Chem. 287:24844-24861. http://dx.doi.org/10.1074/jbc. M112.341321.
12. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71. http://dx.doi.org/10.1038/377068a0.
13. Merk M, Zierow S, Leng L, Das R, Du X, Schulte W, Fan J, Lue H, Chen Y, Xiong H, Chagnon F, Bernhagen J, Lolis E, Mor G, Lesur O, Bucala R. 2011. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc. Natl. Acad. Sci. U. S. A. 108:E577-E585. http://dx.doi.org/10.1073/pnas.1102941108.
14. Senter PD, Al-Abed Y, Metz CN, Benigni F, Mitchell RA, Chesney J, Han J, Gartner CG, Nelson SD, Todaro GJ, Bucala R. 2002. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc. Natl. Acad. Sci. U. S. A. 99:144-149. http://dx.doi.org/10.1073/pnas.011569399.
15. Roger T, Chanson AL, Knaup-Reymond M, Calandra T. 2005. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur. J. Immunol. 35:3405-3413. http://dx.doi.org/10.1002/eji.200535413.
16. Sun T, Holowka T, Song Y, Zierow S, Leng L, Chen Y, Xiong H, Griffith J, Nouraie M, Thuma PE, Lolis E, Janse CJ, Gordeuk VR, Augustijn K, Bucala R. 2012. A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria. Proc. Natl. Acad. Sci. U. S. A. 109:E2117-E2126. http://dx.doi.org/10.1073/pnas.1206573109.
17. de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, Mizoguchi E, Metz CN, Alsahli M, ten Hove T, Keates AC, Lubetsky JB, Farrell RJ, Michetti P, van Deventer SJ, Lolis E, David JR, Bhan AK, Terhorst C. 2001. Development of chronic colitis is dependent on the cytokine MIF. Nat. Immunol. 2:1061-1066. http://dx.doi.org/10.1038/ni720.
18. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R. 2003. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197:1467-1476. http://dx.doi.org/10.1084/jem.20030286.
19. Oliver J, Marquez A, Gomez-Garcia M, Martinez A, Mendoza JL, Vilchez JR, Lopez-Nevot MA, Pinero A, de la Concha EG, Nieto A, Urcelay E, Martin J. 2007. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut 56:150-151. http://dx.doi.org/10.1136/gut.2006.107649.
20. Zhang H, Ma L, Dong LQ, Shu C, Xu JL. 2013. Association of the macrophage migration inhibitory factor gene-173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects. Gene 526:228-231. http://dx.doi.org/10.1016/j.gene.2013.05.012.
21. Nishihira J, Mitsuyama K. 2009. Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease. Curr. Pharm. Des. 15:2104-2109. http://dx.doi.org/10.2174/138161209788489113.
22. Ohkawara T, Koyama Y, Onodera S, Takeda H, Kato M, Asaka M, Nishihira J. 2011. DNA vaccination targeting macrophage migration inhibitory factor prevents murine experimental colitis. Clin. Exp. Immunol. 163:113-122. http://dx.doi.org/10.1111/j.1365-2249.2010.04277.x.
23. Augustijn KD, Kleemann R, Thompson J, Kooistra T, Crawford CE, Reece SE, Pain A, Siebum AH, Janse CJ, Waters AP. 2007. Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor. Infect. Immun. 75: 1116-1128. http://dx.doi.org/10.1128/IAI.00902-06.
24. Cordery DV, Kishore U, Kyes S, ShafiMJ, Watkins KR, Williams TN, Marsh K, Urban BC. 2007. Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue. J. Infect. Dis. 195: 905-912. http://dx.doi.org/10.1086/511309.
25. Shao D, Zhong X, Zhou YF, Han Z, Lin Y, Wang Z, Bu L, Zhang L, Su XD, Wang H. 2010. Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host. Mol. Immunol. 47:726-737. http://dx.doi.org/10.1016/j.molimm.2009.10.037.
26. Miller JL, Harupa A, Kappe SH, Mikolajczak SA. 2012. Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development. Infect. Immun. 80:1399-1407. http://dx.doi.org/10.1128/IAI.05861-11.
27. Kamir D, Zierow S, Leng L, Cho Y, Diaz Y, Griffith J, McDonald C, Merk M, Mitchell RA, Trent J, Chen Y, Kwong YK, Xiong H, Vermeire J, Cappello M, McMahon-Pratt D, Walker J, Bernhagen J, Lolis E, Bucala R. 2008. A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J. Immunol. 180: 8250-8261. http://dx.doi.org/10.4049/jimmunol.180.12.8250.
28. Sommerville C, Richardson JM, Williams RA, Mottram JC, Roberts CW, Alexander J, Henriquez FL. 2013. Biochemical and immunological characterization of Toxoplasma gondii macrophage migration inhibitory factor. J. Biol. Chem. 288:12733-12741. http://dx.doi.org/10.1074/jbc. M112.419911.
29. Loftus B, Anderson I, Davies R, Alsmark UC, Samuelson J, Amedeo P, Roncaglia P, Berriman M, Hirt RP, Mann BJ, Nozaki T, Suh B, Pop M, Duchene M, Ackers J, Tannich E, Leippe M, Hofer M, Bruchhaus I, Willhoeft U, Bhattacharya A, Chillingworth T, Churcher C, Hance Z, Harris B, Harris D, Jagels K, Moule S, Mungall K, Ormond D, Squares R, Whitehead S, Quail MA, Rabbinowitsch E, Norbertczak H, Price C, Wang Z, Guillen N, Gilchrist C, Stroup SE, Bhattacharya S, Lohia A, Foster PG, Sicheritz-Ponten T, Weber C, Singh U, Mukherjee C, El-Sayed NM, Petri WA, Jr, Clark CG, Embley TM, Barrell B, Fraser CM, Hall N. 2005. The genome of the protist parasite Entamoeba histolytica. Nature 433:865-868. http://dx.doi.org/10.1038/nature03291.
30. Ehrenkaufer GM, Haque R, Hackney JA, Eichinger DJ, Singh U. 2007. Identification of developmentally regulated genes in Entamoeba histolytica: insights into mechanisms of stage conversion in a protozoan parasite. Cell. Microbiol. 9:1426-1444. http://dx.doi.org/10.1111/j.1462-5822.2006.00882.x.
31. Dobson SE, Augustijn KD, Brannigan JA, Schnick C, Janse CJ, Dodson EJ, Waters AP, Wilkinson AJ. 2009. The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei. Protein Sci. 18:2578-2591. http://dx.doi.org/10.1002/pro.263.
32. Younis AE, Soblik H, Ajonina-Ekoti I, Erttmann KD, Luersen K, Liebau E, Brattig NW. 2012. Characterization of a secreted macrophage migration inhibitory factor homologue of the parasitic nematode Strongyloides acting at the parasite-host cell interface. Microbes Infect. 14:279-289. http://dx.doi.org/10.1016/j.micinf.2011.09.006.
33. Haque R, Ali IM, Sack RB, Farr BM, Ramakrishnan G, Petri WA, Jr. 2001. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J. Infect. Dis. 183:1787-1793. http://dx.doi.org/10.1086/320740.
34. Singh G. 2007. Determination of cutoffscore for a diagnostic test. Internet J. Lab. Med. 2:1. http://ispub.com/IJLM/2/1/9884.
35. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13:587-596. http://dx.doi.org/10.1038/nm1567.
36. Flieger O, Engling A, Bucala R, Lue H, Nickel W, Bernhagen J. 2003. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett. 551:78-86. http://dx.doi.org/10.1016/S0014-5793(03)00900-1.
37. Greven D, Leng L, Bucala R. 2010. Autoimmune diseases: MIF as a therapeutic target. Expert Opin. Ther. Targets 14:253-264. http://dx.doi.org/10.1517/14728220903551304.
38. Kissoon-Singh V, Moreau F, Trusevych E, Chadee K. 2013. Entamoeba histolytica exacerbates epithelial tight junction permeability and proinflammatory responses in Muc2(-/-) mice. Am. J. Pathol. 182:852-865. http://dx.doi.org/10.1016/j.ajpath.2012.11.035.
39. Eckmann L, Reed SL, Smith JR, KagnoffMF. 1995. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1 alpha. J. Clin. Invest. 96:1269-1279. http://dx.doi.org/10.1172/JCI118161.
40. Jang SI, Lillehoj HS, Lee SH, Kim DK, Pages M, Hong YH, Min W, Lillehoj EP. 2011. Distinct immunoregulatory properties of macrophage migration inhibitory factors encoded by Eimeria parasites and their chicken host. Vaccine 29:8998-9004. http://dx.doi.org/10.1016/j.vaccine.2011.09.038.
41. Bai F, Asojo OA, Cirillo P, Ciustea M, Ledizet M, AristoffPA, Leng L, Koski RA, Powell TJ, Bucala R, Anthony KG. 2012. A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF). J. Biol. Chem. 287:30653-30663. http://dx.doi.org/10.1074/jbc. M112.385583.
42. Miska K, Kim S, Fetterer R, Dalloul R, Jenkins M. 2013. Macrophage migration inhibitory factor (MIF) of the protozoan parasite Eimeria influences the components of the immune system of its host, the chicken. Parasitol. Res. 112:1935-1944. http://dx.doi.org/10.1007/s00436-013-3345-z.
43. Atreya R, Neurath M. 2005. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin. Rev. Allerg. Immunol. 28:187-195. http://dx.doi.org/10.1385/CRIAI:28:3:187.
44. Bernardo D, Vallejo-Díez S, Mann ER, Al-Hassi HO, Martínez-Abad B, Montalvillo E, Tee CT, Murugananthan AU, Núñez H, Peake STC, Hart AL, Fernández-Salazar L, Garrote JA, Arranz E, Knight SC. 2012. IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and T cells they stimulate. Eur. J. Immunol. 42:1337-1353. http://dx.doi.org/10.1002/eji.201142327.
45. Hamano S, Asgharpour A, Stroup SE, Wynn TA, Leiter EH, Houpt E. 2006. Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production. J. Immunol. 177: 1208-1213. http://dx.doi.org/10.4049/jimmunol.177.2.1208.
46. Lawrance IC, Fiocchi C, Chakravarti S. 2001. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum. Mol. Genet. 10:445-456. http://dx.doi.org/10.1093/hmg/10.5.445.
47. Mukherjee C, Clark CG, Lohia A. 2008. Entamoeba shows reversible variation in ploidy under different growth conditions and between life cycle phases. PLoS Negl. Trop. Dis. 2:e281. http://dx.doi.org/10.1371/journal.pntd.0000281.
48. Nielsen OH, Ainsworth MA. 2013. Tumor necrosis factor inhibitors for inflammatory bowel disease. N. Engl. J. Med. 369:754-762. http://dx.doi.org/10.1056/NEJMct1209614.
49. Noti M, Corazza N, Tuffin G, Schoonjans K, Brunner T. 2010. Lipopolysaccharide induces intestinal glucocorticoid synthesis in a TNFalphadependent manner. FASEB J. 24:1340-1346. http://dx.doi.org/10.1096/fj.09-140913.
50. Atanasov AG, Leiser D, Roesselet C, Noti M, Corazza N, Schoonjans K, Brunner T. 2008. Cell cycle-dependent regulation of extra-adrenal glucocorticoid synthesis in murine intestinal epithelial cells. FASEB J. 22:4117-4125. http://dx.doi.org/10.1096/fj.08-114157.
51. Mueller M, Atanasov A, Cima I, Corazza N, Schoonjans K, Brunner T. 2007. Differential regulation of glucocorticoid synthesis in murine intestinal epithelial versus adrenocortical cell lines. Endocrinology 148:1445-1453. http://dx.doi.org/10.1210/en.2006-0591.
52. Coste A, Dubuquoy L, Barnouin R, Annicotte JS, Magnier B, Notti M, Corazza N, Antal MC, Metzger D, Desreumaux P, Brunner T, Auwerx J, Schoonjans K. 2007. LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease. Proc. Natl. Acad. Sci. U. S. A. 104:13098-13103. http://dx.doi.org/10.1073/pnas.0702440104.
53. Mueller M, Cima I, Noti M, Fuhrer A, Jakob S, Dubuquoy L, Schoonjans K, Brunner T. 2006. The nuclear receptor LRH-1 critically regulates extra-adrenal glucocorticoid synthesis in the intestine. J. Exp. Med. 203:2057-2062. http://dx.doi.org/10.1084/jem.20060357.
54. Aeberli D, Yang Y, Mansell A, Santos L, Leech M, Morand EF. 2006. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett. 580:974-981. http://dx.doi.org/10.1016/j.febslet.2006.01.027.
55. Cima I, Corazza N, Dick B, Fuhrer A, Herren S, Jakob S, Ayuni E, Mueller C, Brunner T. 2004. Intestinal epithelial cells synthesize glucocorticoids and regulate T cell activation. J. Exp. Med. 200:1635-1646. http://dx.doi.org/10.1084/jem.20031958.
56. Liu Y, Shepherd EG, Nelin LD. 2007. MAPK phosphatases-regulating the immune response. Nat. Rev. Immunol. 7:202-212. http://dx.doi.org/10.1038/nri2035.
57. Blazquez S, Zimmer C, Guigon G, Olivo-Marin JC, Guillen N, Labruyere E. 2006. Human tumor necrosis factor is a chemoattractant for the parasite Entamoeba histolytica. Infect. Immun. 74:1407-1411. http://dx.doi.org/10.1128/IAI.74.2.1407-1411.2006.
58. Blazquez S, Guigon G, Weber C, Syan S, Sismeiro O, Coppee JY, Labruyere E, Guillen N. 2008. Chemotaxis of Entamoeba histolytica towards the pro-inflammatory cytokine TNF is based on PI3K signalling, cytoskeleton reorganization and the galactose/N-acetylgalactosamine lectin activity. Cell. Microbiol. 10:1676-1686. http://dx.doi.org/10.1111/j.1462-5822.2008.01158.x.
59. Pillai DR, Kain KC. 2005. Entamoeba histolytica: identification of a distinct beta2 integrin-like molecule with a potential role in cellular adherence. Exp. Parasitol. 109:135-142. http://dx.doi.org/10.1016/j.exppara.2004.12.007.
60. Davis PH, Zhang X, Guo J, Townsend RR, Stanley SL, Jr. 2006. Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence. Mol. Microbiol. 61:1523-1532. http://dx.doi.org/10.1111/j.1365-2958.2006.05344.x.
61. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J. 2000. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211-216. http://dx.doi.org/10.1038/35041591.
62. Burger-Kentischer A, Finkelmeier D, Thiele M, Schmucker J, Geiger G, Tovar GE, Bernhagen J. 2005. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. FEBS Lett. 579:1693-1701. http://dx.doi.org/10.1016/j.febslet.2005.01.080.